Vivo Capital’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Vivo Capital’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-225,000	Closed	-$8.19M	–	26
2016 Q4	$8.19M	Hold	225,000	–	–	2.7%	12
2016 Q3	$8.58M	Buy	+225,000	New	+$3.33M	2.68%	11

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Vivo Capital's CLCD Position: Q1 2017 in Review

Vivo Capital sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 225,000 shares — an estimated $8.19M sold.

Vivo Capital first reported a position in CLCD in Q3 2016 and held it in 2 quarters. The position peaked at $8.58M in Q3 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

Vivo Capital reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Vivo Capital sold 225,000 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $8.19M.
Vivo Capital first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
Vivo Capital's CoLucid Pharmaceuticals, Inc. position peaked at $8.58M in Q3 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Vivo Capital's 13F filing for Q1 2017, filed 15 May 2017.